Long-Term safety of mitochondrial drug confirmed in Follow-Up study
NCT ID NCT05218655
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 36 times
Summary
This study looked at the safety of vatiquinone in 101 people with inherited mitochondrial disease who had already taken the drug in earlier studies. Participants continued treatment until the drug became available or the program ended. The main goal was to track any side effects, and the results help doctors understand how safe vatiquinone is for long-term use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INHERITED MITOCHONDRIAL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Akron Children's Hospital
Akron, Ohio, 44308, United States
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
CHU Montpellier - Hopital Saint-Eloi
Montpellier, 34295, France
-
Child Neurology Center of Northwest Florida
Gulf Breeze, Florida, 32561, United States
-
Children's Hospital of Philadelphia - CHOP
Philadelphia, Pennsylvania, 19104, United States
-
Children's National
Washington D.C., District of Columbia, 20010, United States
-
Chu Angers
Angers, 49933, France
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Columbia University Medical Center - CUMC
New York, New York, 10032, United States
-
Great Ormond Street Hospital for Children NHS Foundation Trust
London, WC1N 3JH, United Kingdom
-
Hopital Necker-Enfants Malades
Paris, 75015, France
-
Hospital Ruber Internacional
Madrid, 28034, Spain
-
Hospital Sant Joan de Déu
Barcelona, 08950, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28003, Spain
-
Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg
Strasbourg, 67000, France
-
Instytut Pomnik - Centrum Zdrowia Dziecka
Warsaw, 04-730, Poland
-
Medical University of South Carolina - MUSC
Charleston, South Carolina, 29425, United States
-
Ospedale Pediatrico Bambino Gesù
Roma, 00165, Italy
-
PTC Clinical Site
Japanese City, Japan
-
Seattle Children Hospital
Seattle, Washington, 98105, United States
-
Stanford University
Stanford, California, 94305, United States
-
The Johns Hopkins University
Baltimore, Maryland, 21205, United States
-
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, NE1 4LP, United Kingdom
-
UT Health The University of Texas
Houston, Texas, 77030, United States
-
University of California, San Diego Altman Clinical and Translational Research Institute
La Jolla, California, 92037, United States
-
Yale Medicine
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.